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Oral anticoagulant therapy (OAT) has been used for more than half a century in the 
management and prevention of thromoembolic disorders. Due to somewhat awkward 
phenomena accompanying anticoagulant therapy during dental-surgical interventions, 
d e n t i s t s  h a v e  t o  b e  w e l l  a c quainted with the characteristics of the therapy and the 
measures to be undertaken in the management of patients on OAT. This paper aims to 
present a short overview of the procedures and measures to be undertaken by a dentist 
in the management of patients on OAT. Acta Medica Medianae 2013;52(1):48-51. 
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Introduction 
 
Oral anticoagulant therapy (OAT) has been 
used for more than half a century in the treatment 
and prevention of thromboembolic diseases. OAT 
is commonly a long-term approach, sometimes 
with life-long administration. Clinicians therefore 
have to take care and balance benefits against 
adverse effects of the therapy. If over-dosed, oral 
anticoagulants may lead to prolonged bleeding, 
and insufficient or abruptly stopped OAT may 
lead to complications, manifested as thrombosis 
(1). Due to adverse manifestations associated 
with OAT during dental surgery interventions, 
dentists have to be well acquainted with the 
effects of this approach in disease prevention. In 
this paper, we intend to give an overview of the 
procedures and measures to be undertaken by 
dentists managing the patients on OAT. 
 
Basic properties of OAT 
 
Oral anticoagulants are vitamin K anta-
gonists, reducing by 30-50% the synthesis of 
vitamin K-dependent coagulation factors in the 
liver (2). They do not have an impact on already 
circulating coagulation factors, but for them to be 
able to act, at least three to four days are 
required (the half-life of some of the coagulation 
factors) (3). OAT is most commonly used in the 
following situations (4): 
• Prevention of recurrent stroke in patients 
with atrial fibrillation, prevention of myocardial 
infarction and venous thromboembolism in high 
risk patients. 
• Prevention of systemic embolism in patients 
with artificial heart valves, diseases of mitral 
valves with or without atrial fibrillation, and acute 
myocardial infarction. Prevention in non-valvular 
atrial fibrillation.  
Anticoagulants most commonly used in our 
institutions are presented in Table 1 (3,5,6). In 
order to prevent overdosing or underdosing when 
giving anticoagulant treatment, the action of 
these medications should be monitored by way of 
laboratory tests. They monitor prothrombin time 
(PT) and thrombotest (TT) values. The best and 
most effective indicant in the monitoring of 
activity of anticoagulants is the INR (International 
Normalized Ratio) system. The INR system was 
established by the World Health Organization in 
1983, and in contrast to PT and TT, it was 
devised not to be sensitive to the type of used 
reagent thromboplastin, enabling direct compa-
risons of the results from different laboratories. 
We can withdraw OAT permanently or tempo-
rarily, with normalization of coagulation in 4 to 7 
days. 
 
Dental aspects of patients on OAT 
 
Individual health education activity 
 
It is obvious that most patients on OAT 
have fears related to their underlying disease and 
then to the treatment administered. These fears 
may have an impact on the understanding and 
relationship with their doctor. In the area of 
dental health care, in his everyday activity a 
dentist has to pay much attention to individual 
health education work with these patients. The 
work starts with the initial contact with the 
patient, being gradually developed and extended 
according to a well established program. Acta Medica Medianae 2013, Vol.52(1)                                                                     Dental patients on oral anticoagulant therapy 
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Table 1. Anticoagulants most commonly used in our country 
 
Medicament Dose  T/2  Effect  duration  Maximum therapeutic effect 
Ethylbiscumacetate 
‐  Pelentan 
‐  Tromexane 
300 mg 
25-30 
hours 
4 days  2-3 days 
Acenocoumarol 
‐  Sintrom 1 
1 mg 
8-11 
hours 
2 days  36-48 hours 
Acenocoumarol 
‐  Sintrom 4 
4 mg 
8-11 
hours 
2 days  36-48 hours 
Warfarin sodium 
‐  Farin 
5 mg 
31-50 
hours 
3 days  36-48 hours 
Phenprocoumon 
‐  Marcoumar 
3 mg  6,5 days  4 days  48 hours 
 
A patient has to be warned of any possible 
complication in the practice of dentistry and be 
aware of possible accompanying events such as 
pain, hematoma, bleeding, and other discomforts. 
F u t u r e  v i s i t s  s h o u l d  b e  p l a n n e d ,  w i t h  c o m m u n i -
cation focusing on the patient motivation to 
continue further dental management, offering to 
the patients basic knowledge about postoperative 
course and possible future dental interventions 
(7). 
 
Oral surgery aspects 
 
In the comprehensive review of the 
management of patients on OAT, from the point 
of view of oral surgery, two problems may be 
singled out to be taken care of in parallel: 
-  underlying/basic disease, as the risk 
disease, and 
- oral anticoagulant therapy. 
Conflicting opinions in the literature as to 
these problems have caused case-by-case and 
routinized management of oral surgery patients 
on OAT. The problem is complex and the reasons 
for that are multiple, most common being differing 
recommendations related to the underlying disease  
by doctors in charge; insufficient education of the 
patients as to their disease and anticoagulant 
therapy; and insufficient collaboration of dentists 
and specialists in charge (7,8).  
 
Significance of team approach 
 
Dental management of patients on OAT is 
a complex process, requiring the engagement of 
a team of doctors. The team should comprise: a 
specialist in charge, transfusiologist, and dentist. 
In the team approach to the issue, the underlying 
condition (disease) is carefully considered, the 
use of appropriate anticoagulants is planned, 
their mechanism of action is considered, and OAT 
effects are controlled via appropriate laboratory 
tests. The duty of a dentist in such a team is to 
suggest the most acceptable methods and agents 
inducing local anesthesia and local hemostasis 
(8,9). 
 
Dental procedures in patients on OAT 
 
The whole concept of the adopted doctrine 
of approach to the high risk group of patients on 
OAT is based on the presumption that dental 
procedures should not provoke the transition of 
compensated into decompensated disease phase 
or, in other words, the latent disease phase into 
manifest, full-blown disease (9). 
The risk of significant bleeding in patients 
on OAT and with stable INR within the therapeutic 
limits (2-4) is very low, while the risk of throm-
bosis can be markedly elevated in patients 
temporarily withdrawn from anticoagulant therapy. 
We should therefore bear in mind the attitude 
that oral anticoagulants should not be stopped in 
most of the patients planned for outpatient 
dental surgery intervention, including tooth 
extraction (10). 
Dentists should not disrupt with their thera-
peutic interventions the continuity of admini-
stered OAT, the OAT being of vital importance for 
these patients. Patients on OAT should be managed 
in dental clinics or hospitals with departments 
of oral surgery or maxillofacial surgery. 
 
Patient admission 
 
The duty of a dentist is to obtain valid 
patient history on admission, regardless of the 
a p p a r e n t  o r  r e a l  s i m p l i c i t y  o f  t h e  p r o b l e m .  T h e  
data related to the risk disease and possible use 
of medication(s) are thus provided. A dentist has 
to be able to recognize anticoagulant agents; if 
the findings indicate that the patient at hand is 
on OAT, adequate patient preparation for dental 
intervention should be undertaken. If these are 
the patients who have not been examined for a 
long time, or the underlying disease has 
progressed, the intervention should be planned 
and performed with the approval of the physician 
treating the underlying disease. If these are well 
controlled patients, with fresh findings (not older 
than 24 hours) of the indicants of anticoagulant 
effect (INR) within the therapeutic values (from 
2.0 to 4.0), bleeding can be possibly managed 
using local therapeutic measures of hemostasis. 
However, in these cases as well, consulting the 
physician treating the underlying disease is more 
than just desirable; these consultations should be 
realized whenever it is feasible. Modern techno-
logies employed in the practice of telemedicine 
may be of particular assistance in that regard, 
enabling rapid and simple distant medical consul-
tations between doctors (11). Dental patients on oral anticoagulant therapy                                                                                            Miladinović Milan et al. 
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Choice of the method of anesthesia 
 
Painlessness of a dental intervention is one 
of the cornerstones of trust between patients and 
their dentists, and a prerequisite for successful 
completion of mostly painful or discomforting 
dental interventions. Elimination of pain is there-
fore a must, accomplished in most cases using 
local anesthesia, while in a smaller number of 
cases general anesthesia is used. 
Local anesthesia is the primary method of 
choice, representing one of the safest and 
simplest methods in obtaining reversible pain-
lessness in dentistry practice. Before the use of 
local anesthesia it is necessary to check if the 
patient is prepared for dental surgery and whether 
the INR values are within the therapeutic limits 
(2.0-4.0). Values exceeding the upper limit may 
lead to the risk of prolonged hemorrhage, even 
when only giving local anesthesia. Due to the 
injury of tissues, larger and smaller blood vessels 
encountered by the needle, prolonged internal 
bleeding may occur, leading to the formation of 
smaller or larger haematomas and other possible 
consequences as well (obstruction of airways, 
etc.). 
With appropriate preparation and proper 
monitoring of vital functions even in most serious 
cases, complicated oral surgery interventions 
may be done reasonably safely in general 
anesthesia (9). 
 
Choice of the method of hemostasis 
 
Dental surgery interventions in patients on 
OAT carry a certain degree of risk, possible 
hemorrhage or thromboembolic complications. It 
is vital that a dentist should be well acquainted 
with the procedures of premedication of high risk 
patients, being able to adequately apply them. If 
a patient is properly prepared before dental 
surgery, and hemorrhage occurs after the 
intervention, it can be almost always stopped 
using the standard methods of hemostasis (9). A 
bleeding patient should be carefully examined 
and relaxed. If the wound is in question, as 
mostly is, the loose coagulum from the wound 
surface should be removed, the would should be 
examined, left to dry a bit, and artificial 
hemostasis is then applied. The methods and 
tools of local hemostasis may be combined – a 
number of patients on OAT may require special, 
systemic measures of hemostasis to be applied in 
hospital environment. 
The following measures to reduce the risk 
of bleeding are recommended in patients on OAT 
undergoing oral surgery intervention (10): 
•  Use of oxidized cellulose (Surgicel) or 
collagenous sponges and sutures. 
•  Washing of the mouth cavity with 5% 
tranexamic acid four times a day in the period of 
two days (generally, tranexamic acid is rarely 
available in primary practice of dentistry). 
Procedure of dental surgery intervention 
 
The complete procedure of dental surgery 
intervention should consist of the steps presented 
below (1-10): 
A. Preparation before intervention: 
-  Individual health education activity; 
-  OAT should not be withdrawn neither 
before, nor after the intervention; 
-  INR result values have to be within the 
range 2.0-4.0 on the extraction day. It is thus 
recommended to check INR 72 hours before 
extraction, and adjust OAT so as to be within the 
range 2.0-4.0 on the extraction day (10). 
-  Antibiotic therapy in the prevention of 
bacterial endocarditis, prescribed by a cardio-
logist (it usually consists of amoxicillin, ampicillin, 
clindamycin and azithromycin (12). 
-  Written approval by the specialist treating 
the underlying risk disease. 
B. Intervention: 
-  Choice of anesthesia method (local anesthesia 
is preferred as the safest and simplest approach, 
or some of the sedation techniques accompa-
nying local anesthesia); 
-  Dental surgery procedure (planned based 
on the risk disease, OAT, and patient age); 
-  Choice of hemostasis method (since patho-
logic hemorrhage is in question, with a frail and 
delicate blood coagulum, chemical and biologic 
resorptive tools are desirable, soaked in an anti-
fibrinolytic and locally applied, and as required, 
other means and methods of local hemostasis may 
be used). The use of systemic chemostatics (eg. 
vitamin K, etc.) by dentists is contraindicated. 
C. Post-surgical course: 
-  Antibiotic therapy (prescribed according to 
the dentist’s assessment, consulting the physician 
in charge of the management of underlying 
disease); 
-  Antiinflammatory agents (NSAIDs and COX-2 
inhibitors should not be prescribed as analgesics 
or antipiretics, which refers especially to brufen 
and aspirin); 
-  Measures of local hemostasis (all the 
methods and tools of local hemostasis may be 
used, with the priority of resorptive hemostatics 
combined with antifibrinolytics; systemic hemostasis 
undertaken by a dentist is not permitted); 
-  Bleeding episodes lasting up to four hours 
of oral surgery intervention should be managed 
using the measures of local hemostasis; if the 
period of time is exceeded, support from a 
hematologist or transfusiologist should be 
sought, who would stop the bleeding employing 
the systemic measures of hemostasis. 
 
Conclusion 
 
Based on the literature data and years of 
clinical experience with the patients on OAT for 
their original disease, the paper presents a short 
overview of the dental treatment of this high risk 
patient population. Due to the presence of a 
twofold problem in patients with risk diseases on 
OAT, the awareness of dentists should be constantly Acta Medica Medianae 2013, Vol.52(1)                                                                     Dental patients on oral anticoagulant therapy 
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at a very high level, and the recommendations 
related to patient admission, preparation for inter-
vention, dental surgery itself, and post-surgical 
management the should be closely abided by. 
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STOMATOLOŠKI PACIJENTI NA ORALNOJ ANTIKOAGULANTNOJ 
TERAPIJI 
 
Milan Miladinović, Miloš Duka, Dragan Mladenović, Sanja Mladenović, Lidija Mladenović i 
Mervan Hadžibeti  
 
 
Oralna antikoagulantna terapija (OAT) se koristi više od pola veka u terapiji i 
prevenciji tromboembolijskih oboljenja. Zbog nezgodnih manifestacija koje mogu 
pratiti oralnu antikoagulantnu terapiju prilikom stomatološko-hirurških intervencija, 
stomatolozi moraju biti dobro upoznati sa njenim karakteristikama, ali i merama koje 
treba sprovesti kod zdravstvenog zbrinjavanja pacijenata na OAT. Ovaj rad ima za cilj 
da pruži kratak osvrt na postupke i mere koje stomatolog treba da ima u vidu kada 
zbrinjava pacijenta koji je na OAT. Acta Medica Medianae 2013;52(1):48-51. 
 
Ključne reči: OAT, stomatologija, antikoagulantna terapija, oralna hirurgija 